Insider Trades17 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Sell | STAA | Warren Foust | President and CEO | 10,576 | $24.36 | $1.1B | -36.83% | +45.40% | $257.6K | -10.89% | — | Trim |
| Jun 25, 2026 | Sell | STAA | Deborah J Andrews | Chief Financial Officer & EVP | 17,056 | $26.96 | $1.1B | -36.83% | +45.40% | $459.9K | -15.88% | — | Trim |
| May 15, 2026 | Sell | STAA | Deborah J Andrews | Interim Co-CEO and CFO | 5,632 | $32.07 | $1.1B | -36.83% | +45.40% | $180.6K | -8.57% | — | Trim |
| May 15, 2026 | Sell | STAA | Magda Michna | Chief Development Officer | 9,703 | $32.07 | $1.1B | -36.83% | +45.40% | $311.2K | -4.04% | — | Trim |
| May 15, 2026 | Sell | STAA | Warren Foust | Interim Co-CEO and Pres. & COO | 16,785 | $32.07 | $1.1B | -36.83% | +45.40% | $538.3K | -3.89% | — | Trim |
| May 8, 2026 | Sell | STAA | Magda Michna | Chief Development Officer | 1,680 | $26.69 | $1.1B | -36.83% | +45.40% | $44.8K | -4.89% | — | Trim |
| May 8, 2026 | Sell | STAA | Warren Foust | Interim Co-CEO and Pres. & COO | 3,448 | $26.69 | $1.1B | -36.83% | +45.40% | $92.0K | -4.90% | — | Trim |
| Mar 12, 2026 | Sell | STAA | Magda Michna | Chief Development Officer | 8,529 | $18.72 | $1.1B | -36.83% | +45.40% | $159.7K | -6.47% | — | Trim |
| Dec 11, 2025 | Sell | STAA | Nathaniel Sisitsky | Chief Legal Officer | 2,616 | $24.68 | $1.1B | -36.83% | +45.40% | $64.6K | -10.29% | — | Trim |
| May 8, 2025 | Sell | STAA | Magda Michna | Chief Development Officer | 1,675 | $19.53 | $1.1B | -36.83% | +45.40% | $32.7K | -10.39% | — | Trim |
| Mar 12, 2025 | Sell | STAA | Nathaniel Sisitsky | General Counsel | 2,334 | $18.00 | $1.1B | -36.83% | +45.40% | $42.0K | -5.92% | — | Trim |
| Mar 12, 2025 | Sell | STAA | Magda Michna | Chief Clinical, Regulatory, | 2,435 | $18.00 | $1.1B | -36.83% | +45.40% | $43.8K | -7.88% | — | Trim |
| Mar 5, 2025 | Buy | STAA | Stephen C Farrell | President & CEO | 20,000 | $6.95 | $1.1B | -36.83% | +45.40% | $138.9K | +49.61% | — | Trim |
| Jan 3, 2025 | Sell | STAA | Thomas G Frinzi | President & CEO | 10,775 | $24.54 | $1.1B | -36.83% | +45.40% | $264.4K | -13.25% | — | Trim |
| May 8, 2024 | Sell | STAA | Magda Michna | Chief Clinical, Regulatory, | 1,670 | $41.02 | $1.1B | -36.83% | +45.40% | $68.5K | -11.89% | — | Trim |
| May 8, 2024 | Sell | STAA | Warren Foust | Chief Operating Officer | 2,418 | $41.02 | $1.1B | -36.83% | +45.40% | $99.2K | -11.89% | — | Trim |
| Jan 3, 2024 | Sell | STAA | Thomas G Frinzi | President & CEO | 10,739 | $29.20 | $1.1B | -36.83% | +45.40% | $313.6K | -11.67% | — | Trim |